scispace - formally typeset
L

Laura Schreiner

Researcher at Ludwig Maximilian University of Munich

Publications -  9
Citations -  568

Laura Schreiner is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Cancer cell & Anoikis. The author has an hindex of 9, co-authored 9 publications receiving 514 citations.

Papers
More filters
Journal ArticleDOI

Nanosized Multifunctional Polyplexes for Receptor-Mediated SiRNA Delivery

TL;DR: A monodisperse and multifunctional carrier system, synthesized by solid phase supported chemistry, for siRNA delivery in vitro and in vivo showed stability in vivo, receptor-specific cell targeting, and silencing of the EG5 gene in receptor-positive tumors.
Journal ArticleDOI

The V-ATPase-inhibitor Archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1

TL;DR: The results indicate that archazolid effectively decreases metastatic dissemination of breast tumors by impairing the trafficking and spatially restricted activation of EGFR and Rho-GTPase Rac1, which are pivotal for directed movement of cells.
Journal ArticleDOI

Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes.

TL;DR: Nine sequence-defined, polycationic oligomers were synthesized containing motifs of three consecutive tyrosines (Y3) as stabilizing components for pDNA and siRNA polyplex assembly, which resulted in significantly reduced tumor growth compared to animal treated with control si RNA polyplexes.
Journal ArticleDOI

V-ATPase Inhibition Regulates Anoikis Resistance and Metastasis of Cancer Cells

TL;DR: V-ATPase inhibition is not only an interesting option to reduce cancer metastasis, but also to better understand anoikis resistance and to find choices to fight against it.
Journal ArticleDOI

V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo

TL;DR: Results show that inhibition of V‐ATPase by archazolid reduces the activity of prometastatic proteases like cathepsin B in vitro and in vivo.